Sana Biotechnology Inc (SANA)

$3.11 -0.06 (-1.89%)
Market Cap 835.29M
Revenue (ttm) 0.00
Net Income (ttm) -244.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 9,276,800
Avg Vol 2,521,158
Day's Range N/A - N/A
Shares Out 266.87M
Stochastic %K 23%
Beta 1.96
Analysts Strong Sell
Price Target $8.43

Company Profile

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modifi...

Industry: Biotechnology
Sector: Healthcare
Phone: 206 701 7914
Address:
188 East Blaine Street, Suite 400, Seattle, United States
red1
red1 Mar. 20 at 10:33 PM
$ELDN $SANA $VRTX what do you guys think? Why such big moves?
1 · Reply
red1
red1 Mar. 20 at 9:05 PM
$ELDN $VRTX $SANA All had massive volume spike at the end… big volume AH … I wonder why? Islet act? Partnership collab?
0 · Reply
BriOnH
BriOnH Mar. 20 at 6:30 PM
$SANA For better or for worst I am 100% prepared to accept that the IND and Phase 1 _might_ not happen this year. Given the track record with Sana: it's going to be late, but it's going to work. We have heard revolving/evolving language of: "The company expects to file an IND application for SC451 and begin a Phase 1 trial as early as this year. Believe me, I friggen want it right effin now, but reality is I am prepared not to be disappointed here, again, given their past track record. If it does get done on time, heck if IND happens like next month, F yeah! I also expected the Beta cells to exhaust by now, and I was wrong on that, so hope to be wrong here too. I'd honestly hate to see this board turn on Harr, as I believe he has been doing everything he can to get this working, and protecting our investments as best as he can. So I am just asking that you prepare yourselves in the case the IND/Phase 1 doesn't happen this year, but I have faith it's going to work.
0 · Reply
JerryMalone32
JerryMalone32 Mar. 20 at 4:45 PM
$SANA
0 · Reply
Theflash88
Theflash88 Mar. 20 at 4:20 PM
$SANA Disappointing stock.. will hold for now.
0 · Reply
BBraggHillBoys
BBraggHillBoys Mar. 19 at 9:29 PM
$SANA narrative to proof this year
0 · Reply
BriOnH
BriOnH Mar. 19 at 5:20 PM
$SANA $ELDN
1 · Reply
History101
History101 Mar. 18 at 3:56 PM
$SANA adding at these levels...GLTALs!!
0 · Reply
OnlyInvestor
OnlyInvestor Mar. 18 at 2:46 PM
$SANA I feel like I’m looking at my DEXCOM feed after bolus’ing too early for pizza then walking through a mall for an hour #iykyk
0 · Reply
LoveRetailFroth
LoveRetailFroth Mar. 18 at 1:35 PM
$RXRX Good Morning ☕️ 💎s $SANA $AMLX $TEMT
0 · Reply
Latest News on SANA
Sana Biotechnology, Inc. (SANA) Presents at The Citizens Life Sciences Conference 2026 Transcript

Mar 18, 2026, 4:52 AM EDT - 3 days ago

Sana Biotechnology, Inc. (SANA) Presents at The Citizens Life Sciences Conference 2026 Transcript

Sana Biotechnology, Inc. (SANA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 6, 2026, 1:46 PM EST - 15 days ago

Sana Biotechnology, Inc. (SANA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Mar 3, 2026, 4:05 PM EST - 18 days ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Sana Biotechnology to Present at March 2026 Investor Conferences

Feb 23, 2026, 4:05 PM EST - 26 days ago

Sana Biotechnology to Present at March 2026 Investor Conferences

Sana Biotechnology: A Small, Speculative Play

Feb 13, 2026, 3:24 AM EST - 5 weeks ago

Sana Biotechnology: A Small, Speculative Play

Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips

Jan 19, 2026, 7:40 AM EST - 2 months ago

Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips

Sana Biotechnology, Inc. (SANA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 3:26 PM EST - 2 months ago

Sana Biotechnology, Inc. (SANA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 4:26 PM EST - 2 months ago

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Dec 8, 2025, 9:00 AM EST - 3 months ago

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Sana Biotechnology, Inc. (SANA) Presents at Evercore 8th Annual Healthcare Conference Transcript

Dec 3, 2025, 5:03 PM EST - 3 months ago

Sana Biotechnology, Inc. (SANA) Presents at Evercore 8th Annual Healthcare Conference Transcript

Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 2, 2025, 5:43 PM EST - 3 months ago

Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Sana Biotechnology to Present at December 2025 Investor Conferences

Nov 24, 2025, 4:05 PM EST - 4 months ago

Sana Biotechnology to Present at December 2025 Investor Conferences

Sana Biotechnology: Scope Goes Beyond HIP-Modified Pancreatic Islet Cells For T1D

Oct 16, 2025, 5:09 PM EDT - 5 months ago

Sana Biotechnology: Scope Goes Beyond HIP-Modified Pancreatic Islet Cells For T1D

Sana Biotechnology: A Big Winner In Waiting? Maybe, But It Won't Happen Overnight

Oct 16, 2025, 4:18 PM EDT - 5 months ago

Sana Biotechnology: A Big Winner In Waiting? Maybe, But It Won't Happen Overnight

Sana Biotech Stock — The Next '100-Bagger'?

Oct 15, 2025, 12:15 PM EDT - 5 months ago

Sana Biotech Stock — The Next '100-Bagger'?

Sana Biotechnology, Inc. (SANA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 4:34 PM EDT - 6 months ago

Sana Biotechnology, Inc. (SANA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sana Biotechnology, Inc. (SANA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 5, 2025, 1:42 AM EDT - 7 months ago

Sana Biotechnology, Inc. (SANA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sana Biotechnology, Inc. (SANA) Presents At Citi's Biopharma Back To School Conference Transcript

Sep 2, 2025, 10:03 PM EDT - 7 months ago

Sana Biotechnology, Inc. (SANA) Presents At Citi's Biopharma Back To School Conference Transcript

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

Aug 28, 2025, 8:00 AM EDT - 7 months ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX IQV MRNA

Sana Biotechnology to Present at September 2025 Investor Conferences

Aug 26, 2025, 4:05 PM EDT - 7 months ago

Sana Biotechnology to Present at September 2025 Investor Conferences

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

Aug 20, 2025, 4:05 PM EDT - 7 months ago

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued

Aug 8, 2025, 2:58 PM EDT - 8 months ago

Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued

Sana Biotechnology Announces Pricing of Public Offering

Aug 6, 2025, 11:24 PM EDT - 8 months ago

Sana Biotechnology Announces Pricing of Public Offering

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Aug 6, 2025, 4:38 PM EDT - 8 months ago

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 6, 2025, 7:00 AM EDT - 8 months ago

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

MCRB

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Aug 4, 2025, 11:35 AM EDT - 8 months ago

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Jun 23, 2025, 10:05 AM EDT - 9 months ago

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Two Biotech Stocks Poised For Big Moves On Monday

Jun 23, 2025, 7:39 AM EDT - 9 months ago

Two Biotech Stocks Poised For Big Moves On Monday

LCTX

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Jun 9, 2025, 4:05 PM EDT - 10 months ago

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Sana Biotechnology to Present at June 2025 Investor Conferences

May 28, 2025, 4:05 PM EDT - 10 months ago

Sana Biotechnology to Present at June 2025 Investor Conferences

Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment

May 19, 2025, 3:10 PM EDT - 10 months ago

Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment

The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants

May 19, 2025, 11:57 AM EDT - 10 months ago

The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

May 14, 2025, 2:50 PM EDT - 11 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

May 12, 2025, 4:05 PM EDT - 11 months ago

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit - SANA

May 8, 2025, 5:45 AM EDT - 11 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit - SANA

red1
red1 Mar. 20 at 10:33 PM
$ELDN $SANA $VRTX what do you guys think? Why such big moves?
1 · Reply
red1
red1 Mar. 20 at 9:05 PM
$ELDN $VRTX $SANA All had massive volume spike at the end… big volume AH … I wonder why? Islet act? Partnership collab?
0 · Reply
BriOnH
BriOnH Mar. 20 at 6:30 PM
$SANA For better or for worst I am 100% prepared to accept that the IND and Phase 1 _might_ not happen this year. Given the track record with Sana: it's going to be late, but it's going to work. We have heard revolving/evolving language of: "The company expects to file an IND application for SC451 and begin a Phase 1 trial as early as this year. Believe me, I friggen want it right effin now, but reality is I am prepared not to be disappointed here, again, given their past track record. If it does get done on time, heck if IND happens like next month, F yeah! I also expected the Beta cells to exhaust by now, and I was wrong on that, so hope to be wrong here too. I'd honestly hate to see this board turn on Harr, as I believe he has been doing everything he can to get this working, and protecting our investments as best as he can. So I am just asking that you prepare yourselves in the case the IND/Phase 1 doesn't happen this year, but I have faith it's going to work.
0 · Reply
JerryMalone32
JerryMalone32 Mar. 20 at 4:45 PM
$SANA
0 · Reply
Theflash88
Theflash88 Mar. 20 at 4:20 PM
$SANA Disappointing stock.. will hold for now.
0 · Reply
BBraggHillBoys
BBraggHillBoys Mar. 19 at 9:29 PM
$SANA narrative to proof this year
0 · Reply
BriOnH
BriOnH Mar. 19 at 5:20 PM
$SANA $ELDN
1 · Reply
History101
History101 Mar. 18 at 3:56 PM
$SANA adding at these levels...GLTALs!!
0 · Reply
OnlyInvestor
OnlyInvestor Mar. 18 at 2:46 PM
$SANA I feel like I’m looking at my DEXCOM feed after bolus’ing too early for pizza then walking through a mall for an hour #iykyk
0 · Reply
LoveRetailFroth
LoveRetailFroth Mar. 18 at 1:35 PM
$RXRX Good Morning ☕️ 💎s $SANA $AMLX $TEMT
0 · Reply
Smoore1212
Smoore1212 Mar. 17 at 11:15 PM
$ELDN $SANA gives hope to me as a father of a type 1. Invest early. This will happen
2 · Reply
jamesmckevitt
jamesmckevitt Mar. 17 at 3:46 PM
$SANA happy St Patrick’s Day 🇮🇪☘️💚 Here’s to curing T1D 👌🙏👍
1 · Reply
LoveRetailFroth
LoveRetailFroth Mar. 17 at 1:47 PM
$ARBE Good Morning ☕️ About Time🚀 $RXRX $SANA $AMLX
0 · Reply
Salehoz
Salehoz Mar. 16 at 7:20 PM
$SANA You are not buying a company. You are buying a scientific platform bet. Most outcomes look like: • 60% → failure / dilution / sideways • 30% → moderate success ($6-$10) • 10% → breakthrough ($20+) That asymmetry is why venture capital stays invested. High risk. But sometimes the biggest opportunities live exactly there
0 · Reply
prismmarketview
prismmarketview Mar. 16 at 6:45 PM
Sana Biotechnology $SANA Reports 14-Month Insulin Production in Type 1 Diabetes Cell Therapy Study https://prismmarketview.com/sana-biotechnology-reports-14-month-insulin-production-in-type-1-diabetes-cell-therapy-study/
0 · Reply
Esau815
Esau815 Mar. 14 at 1:32 PM
$SANA I'd like to defer to BrionH because he knows more than I do and is a gentleman through and through. But my impressions are: 1. The 14 month data is of course promising. I wish that patient continued good health. 2. The platform itself could be a springboard to many more indications than T1D. 3. However, the big concern is manufacturing of islet cells. Patient 0 is using cadaver cells which are commercially non viable. Hoping (praying) that SANA can crack this manufacutring issue before their cash runs dry.
1 · Reply
OnlyInvestor
OnlyInvestor Mar. 14 at 3:19 AM
$SANA There’s only 2 types of people in this thread. Type 1 Diabetics, and people who listen to Eric Jackson slop.
1 · Reply
History101
History101 Mar. 13 at 10:57 PM
$SANA added today
0 · Reply
BBraggHillBoys
BBraggHillBoys Mar. 13 at 7:45 PM
$SANA
0 · Reply
BriOnH
BriOnH Mar. 13 at 6:49 PM
$SANA Keep in mind T1D is just the tip of the iceberg here, the proving grounds, for a future where organs, and cell types we haven't even imagined yet, ones that could potentially deliver biological medications, can be transplanted in to the human body without rejection. As big as AI is right now, IMHO I believe this step is equally as paramount to humanity. We can't even begin to fathom ways this tech can be used, because until up421, it was never an option.
0 · Reply
Scrapps64
Scrapps64 Mar. 13 at 6:10 PM
$SANA Consider yourself lucky if you own a piece of this game changing company. If you are not diabetic, you truly have no idea what this news means…
0 · Reply
BriOnH
BriOnH Mar. 13 at 5:02 PM
$SANA I am rather shocked by the results here. Remember only 5% of the islets needed for a fx cure was given. At months 9-12 we started to see C-peptide decreasing, meaning less insulin was being made by the beta cells in the islets, however here at 14 months c-peptide is now back at the initial 6 month level. I think we all expected these islets to be exhausted by now, much like islets are exhausted in type 2 diabetes from working too hard, but the opposite has happened... Why? I am a bit dumbfounded here. I can't imagine that engraftment takes 1 year in muscle vs 4-6 weeks via the Edmonton Protocol. Maybe lower glucose stress with better control, the press release mentioned better glycemic control so maybe the beta cells are actually getting a chance to chill in regular glucose levels. Whatever the case, and I am interested in specifics there if you have a theory or I just missed it, in what's going there, but wow. 14 months out and not only working, but thriving even more.
2 · Reply